Calpain as proposed target for neuroprotective treatment of brain ischemia

Folia Neuropathologica

Volumn 34, Issue 3, 1996, Pages

  Zalewska, Teresa ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Calpain; Ischemia; Neuronal damage; Neuroprotection; Proteolysis

Indexed keywords

EID: 3242756951     PISSN: 00283894     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Adachi E, Mukaiyama T, Sasai K, Hayashi T, Kawashima S, Kasai Y, Hayashi M, Hashimoto P: Immunohistochemical evidence of the extracellular localization of calcium-activated neutral protease (CANP) in rabbit skeletal muscle, lung and aorta. Arch Histol Cytol, 1990, 53, 413-422.
2. Arai A, Kessler M, Lee K, Lynch G: Calpain inhibitors improve the recovery of synaptic transmission from hypoxia in hippocampus slices. Brain Res, 1990, 532, 63-68.
3. Arai A, Vanderklish P, Kessler M, Lee K, Lynch G: A brief period of hypoxia causes proteolysis of cytoskeletal proteins in hippocampal slices. Brain Res, 1991, 555, 276-280.
4. Arlinghaus L, Mehdi S, Lee KS: Improved posthypoxic recovery with a membrane-permeable calpain inhibitor. Europ J Pharm, 1991, 209, 123-125.
5. Bartus RT, Baker KL, Heiser AD, Sawyers D, Dean RL, Elliot PJ, Straub JA: Postischemic administration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damage. J Cerebr Blood Flow Metab, 1994, 14, 537-544.
6. Bartus RT, Dean RL, Cavanough K, Eveleth D, Carriero DL, Lynch G: Time-related neuronal changes following middle cerebral artery occlusion: implications for therapeutic intervention and the role of calpain. J Cerebr Blood Flow Metab, 1995, 15, 969-979.
7. Blomgren K, Kawashima S, Saido TC, Karlsson JO, Elemered A, Hagberg H: Fodrin degradation and subcellular distribution of calpains after neonatal rat cerebral hypoxic-ischemia. Brain Res, 1995, 684, 143-149.
8. 2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells. J Neurosci, 1994, 14, 187-197.
9. Choi DW: Glutamate neurotoxicity and diseases of the nervous system. Neuron, 1988, 1, 623-624.
10. Croall DE, DeMartino GN: Calcium-activated neutral protease (calpain) system: structure, function and regulation. Physiol Rev, 1991, 71, 813-847.
11. Fukuda T, Adachi E, Kawashima S, Yoshiya I, Hashimoto PH: Immunohistochemical distribution of calcium-activated neutral proteinases and endogenous CANP inhibitor in the rabbit hippocampus. J Comp Neurol, 1990, 302, 100-109.
12. Goll DE, Thompson VF, Taylor RG, Zalewska T: Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? BioEssays, 1992, 14, 549-556.
13. Hamakubo T, Kannagi R, Murachi T, Matus A: Distribution of calpains I and II in rat brain. J Neurosci, 1986, 6, 3103-3111.
14. Hiramatsu KI, Kassell NF, Lee KS: Improved posthypoxic recovery of synaptic transmission in gerbil neocortical slices treated with a calpain inhibitor. Stroke, 1993, 24, 1725-1728.
15. Hong SC, Goto Y, Lanzino G, Soleau S, Kassel NF, Lee KS: Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke, 1994, 25, 663-669.
16. Inuzuka T, Tamura A, Sato S, Kirino T, Toyoshima Y, Miyatake T: Suppressive effect of E64c on ischemic degradation of cerebral proteins following occlusion of the midle cerebral artery in rats. Brain Res, 1990, 526, 177-179.
17. Kamakura K, Ishiura S, Imajoh S, Nagata N, Sugita H: Distribution of calcium-activated neutral protease inhibitor in the central nervous system of the rat. J Neurosci Res, 1992, 31, 543-548.
18. Kirino T: Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res, 1982, 239, 57-69.
19. Kirino T, Tamura A, Sano K: Delayed neuronal death in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol, 1984, 64, 139-147.
20. Kishimoto A, Mikawa K, Hashimoto K, Yasuda I, Tanaka S, Tominaga M, Kuroda T, Nishizuka Y: Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). J Biol Chem, 1989, 264, 4088-4092.
21. Lasek RJ, Hoffman PN: The neural cytoskeleton, axonal transport and axonal growth. In Cell Motility. Eds: Goldman R, Pollard T, Rosenbaum J (Cold Spring Harbor, New York: Cold Spring Harbor Laboratory), 1976, pp 1021-1049.
22. Lee KS, Frank S, Vanderklish P, Arai A, Lynch G: Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc Natl Acad Sci USA, 1991, 88, 7233-7237.
23. Li Z, Patil GS, Golubski ZE: Peptide α-ketoester, a-ketoamid and α-ketoacid inhibitors of calpain and other cysteine proteases. J Med Chem, 1993, 36, 3472-3480.
24. Lynch G, Baudry M: The biochemistry of memory: a new and specific hypothesis. Science Wash. DC, 1984, 224, 1057-1063.
25. McGowan EB, Becker E, Detwiler TC: Inhibition of calpain in impact platelets by the thiol protease inhibitor E-64d. Biochem Biophys Res Commun, 1989, 158, 432-435.
26. Meldrum BS: Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitter. Clin Sci, 1985, 68, 113-122.
27. Mellgren RI, Song K, Mericle MT: m-calpain requires DNA for activity on nuclear proteins at low calcium concentrations. J Biol Chem, 1993, 269, 653-657.
28. Melloni E, Pontremoli S: The calpain-calpastatin system: structural and functional properties. J Nutr Biochem, 1991, 2, 467-476.
29. Nixon RA: Fodrin degradation by calcium-activated neutral proteinase (CANP) in retinal ganglion cell neurons and optic glia: preferential localization of CANP activities in neurons. J Neurosci, 1986, 6, 1264-1271.
30. Onizuka K, Kunimatsu M, Ozaki Y, Muramatsu K, Sasaki M, Nishino H: Distribution of μ-calpain proenzyme in the brain and other neural tissues in the rat. Brain Res, 1995, 697, 179-186.
31. Ostwald K, Hayashi M, Nakamura M, Kawashima S: Subcellular distribution of calpain and calpastatin immunoreactivity and fodrin proteolysis in rabbit hippocampus after hypoxia and glucocorticoid treatment. J Neurochem, 1994, 63, 1069-1076.
32. Rami A, Krieglstein J: Protective effects of calpain inhibitors against neuronal damage casued by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res, 1993, 609, 67-70.
33. Roberts-Lewis JM, Savage MJ, Marcy VR, Pinsker LR, Siman R: Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J Neurosci, 1994, 14, 3934-3944.
34. Saido T, Sorimachi H, Suzuki K: New perspectives in molecular diversity and physiological-pathological involvement. FASEB, 1994, 814-822.
35. Seubert P, Lee K, Lynch G: Ischemia triggers NMDA receptor-linked cytoskeletal proteolysis in hippocampus. Brain Res, 1989, 492, 366-370.
36. Siesjö BK, Bengtsson F: Calcium fluxes, calcium antagonists and calcium related pathology in brain ischemia and spreading depression: an unifying hypothesis. J Cereb Blood Flow Metab, 1989, 9, 127-140.
37. Siman R, Ahdoot M, Lynch G: Ontogeny, compartmentation, and turnover of spectrin isoforms in rat central neurons. J Neurosci, 1987, 7, 55-64.
38. Siman R, Noszek JC: Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron, 1988, 1, 279-287.
39. Siman R: Role of calpain I in excitatory amino-acid induced degenerative structural changes. In: Neurotoxicity of excitatory amino acids. Ed: A Guidotii, Raven, New York, 1990, pp 145-161.
40. Sorimachi H, Toyama-Sorimachi N, Saido TC, Kawasaki H, Sugita H, Miyasaka M, Arahata K, Ishiura S, Suzuki K: Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. J Biol Chem, 1993, 268, 10593-10605.
41. Ton H, Arai A, Eveleth D, Bartus R, Lunch G: Ketoamide calpain inhibitors protect hippocampal slices from hypoxia. Soc Neurosci Abstr, 1993, 19, 641.
42. 2+-dependent proteinase (calpain) activity in a plant species, Elodea densa. Life Sci, 1989, 45, 2093-2101.
43. Zalewska T, Domańska-Janik K: On the mechanism of calpain activation under ischemia. J Neurochem, 1996, suppl 2, S23C.
44. Zivin JA, Choi DW: Stroke therapy. Sci AM, 1991, 2654, 56-63.